These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 23265285)
41. Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease. Price DB; Rigazio A; Buatti Small M; Ferro TJ J Asthma Allergy; 2016; 9():145-54. PubMed ID: 27616891 [TBL] [Abstract][Full Text] [Related]
42. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients. Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070 [TBL] [Abstract][Full Text] [Related]
43. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit. Ballard J; Lugo RA; Salyer JW Respir Care; 2002 Jan; 47(1):31-8. PubMed ID: 11749685 [TBL] [Abstract][Full Text] [Related]
44. Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber. Hendeles L; Hatton RC; Coons TJ; Carlson L Am J Health Syst Pharm; 2005 May; 62(10):1053-61. PubMed ID: 15901590 [TBL] [Abstract][Full Text] [Related]
45. Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler. Everard ML; Devadason SG; Summers QA; Le Souëf PN Thorax; 1995 Jul; 50(7):746-9. PubMed ID: 7570408 [TBL] [Abstract][Full Text] [Related]
46. A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers. Snider MA; Wan JY; Jacobs J; Kink R; Gilmore B; Arnold SR J Emerg Med; 2018 Jul; 55(1):7-14. PubMed ID: 29716819 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC; Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704 [TBL] [Abstract][Full Text] [Related]
48. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol. Peyron ID; Britto IL; Benissan LB; Tardieu BZ Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605 [TBL] [Abstract][Full Text] [Related]
52. Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma. Geoffroy P; Lalonde RL; Ahrens R; Clarke W; Hill MR; Vaughan LM; Grossman J Ann Allergy Asthma Immunol; 1999 Apr; 82(4):377-82. PubMed ID: 10227336 [TBL] [Abstract][Full Text] [Related]
53. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ramsdell JW; Colice GL; Ekholm BP; Klinger NM Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics, pharmacodynamics, and clinical efficacy of albuterol RespiClick(™) dry-powder inhaler in the treatment of asthma. Welch MJ Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1109-19. PubMed ID: 27424535 [TBL] [Abstract][Full Text] [Related]
55. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma. von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821 [TBL] [Abstract][Full Text] [Related]
57. Effects of salbutamol given by metered-dose inhaler on dispersion of ventricular repolarization. Polat TB; Saz EU; Nursoy MA Anadolu Kardiyol Derg; 2011 May; 11(3):232-6. PubMed ID: 21501995 [TBL] [Abstract][Full Text] [Related]
58. A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD. Quinn D; Seale JP; Reisner C; Fischer T; Golden M; Fernandez C; Darken P; St Rose E; Thomas M; Tardie G; Orevillo C Respir Med; 2014 Sep; 108(9):1327-35. PubMed ID: 25060541 [TBL] [Abstract][Full Text] [Related]
59. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
60. Final count down to hfa albuterol inhalers: are we ready as yet? Butt AT; Kamat D; Pansare M Clin Pediatr (Phila); 2009 Mar; 48(2):131-4. PubMed ID: 19015282 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]